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Epilepsy is a worldwide public health concern associated with debilitating 
neurological, cognitive, and psychosocial consequences. Current antiepileptic drugs can 
have debilitating side effects and new treatments are needed for individuals with 
pharmaco-resistant seizures like those observed in temporal lobe epilepsy (TLE). Ellagic 
acid (EA), a polyphenol present in several fruits and nuts, has shown beneficial effects in 
rodent models of epilepsy and anxiety, possibly mediated through GABAergic pathways. 
Bang-Sensitive Drosophila mutants model epileptic seizures following mechanical shock 
and provide a high-throughput alternative to costly rodent studies. The objectives of this 
study were to: 1) examine the effectiveness of seizure modeling in two Bang-Sensitive 
mutants strains [bang senseless (bss) and easily shocked (eas)], 2) explore the 
anticonvulsant effects of EA, and 3) investigate EA’s mechanism of action through the 
addition of two types of GABA antagonists: flumazenil (FL) and picrotoxin (PTX). The 
results indicated that vortexing consistently induced seizure-like activity (SLA) in both 
mutant strains. When examining control groups, bss flies exhibited more severe SLA 
when compared to eas flies. EA slightly reduced SLA in bss flies while both GABA 
antagonists increased SLA; however these effects were non-significant. Eas flies 
 xii 
receiving EA exhibited significantly less SLA when compared to bss flies. Both GABA 
antagonists significantly increased SLA in eas flies, with PTX exerting the strongest 
effect. This possibly indicates that EA’s anticonvulsant effect involves GABAergic 
systems in a strain-specific manner and may be more likely mediated through a GABAA 
receptor site than benzodiazepine site. Moreover, utilizing Bang-Sensitive mutants with 
varying levels of seizure-sensitivity provides a valuable tool for screening plant-based 
compounds that can be utilized in the treatment of refractory TLE. 
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CHAPTER ONE 
INTRODUCTION 
 
What are Seizures? 
According to the International League Against Epilepsy (ILAE) and 
International Bureau of Epilepsy (IBE), an epileptic seizure is “a transient occurrence of 
signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the 
brain (Fisher et al., 2005).” Seizures can involve one (focal) or both hemispheres 
(generalized) of the brain, be accompanied with (complex) or without (simple) an altered 
state of consciousness, and be convulsive or non-convulsive (Kammerman & 
Wasserman, 2001). Seizures can also be induced by various triggers such as visual, 
somatosensory, and complex stimuli as well as by higher-ordered cerebral functions 
(Striano, Coppola, del Gaudio, & Striano, 2012). The six types of generalized seizures are 
absence, myoclonic, clonic, tonic, tonic-clonic, and atonic seizures (Kammerman & 
Wasserman, 2001).  
 
What is Epilepsy? 
The ILAE defines epilepsy as a neurological disease characterized by “at least 
two unprovoked (or reflex) seizures occurring less than 24 hours apart, one unprovoked 
(or reflex) seizure and a probability of further seizures similar to the general recurrence 
risk (at least 60%) after two unprovoked seizures occurring over the next 10 years, or a 
diagnosis of an epilepsy syndrome (Fisher et al., 2014).” In addition, status epilepticus, 
which can be life threatening, occurs when there is 5 or more minutes of constant seizure 
activity or recurrent seizure activity without recovery to baseline between seizures 
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(Brophy et al., 2012). 
This disease is a worldwide public health concern that affects approximately 65 
million people (Thurman et al., 2011), as it is the third most common neurological 
disease after Alzheimer’s disease and stroke (Kammerman & Wasserman, 2001). 
Moreover, the incidence of epilepsy and median prevalence rates for lifetime epilepsy 
and active epilepsy are higher in developing countries in comparison to developed 
countries (Ngugi, Bottomley, Kleinschmidt, Sander, & Newton, 2010; Thurman et al., 
2011). In terms of medically refractory seizures, 30-40% of cases are in developed 
countries and individuals with epilepsy in developing countries may be at-risk for not 
receiving any medical treatment (Szilagyi, Szava, Metz, Mihaly, & Orban-Kis, 2014). As 
such, the need for effective treatments is an imperative concern for industrialized and 
non-industrialized societies.  
Temporal lobe epilepsy (TLE) is the most common form of epilepsy in adults 
(Morgan, Conrad, Abou-Khalil, Rogers, & Kang, 2015) as well the most drug-resistant 
(Freiman, Eismann-Schweimler, & Frotscher, 2011). Furthermore, TLE is associated 
with damage to multiple brain structures (Bonilha et al., 2010; Focke et al., 2008), 
cognitive deficits (Alessio et al., 2006; Kaaden & Helmstaedter, 2009), psychiatric 
disorders (Garcia, 2012; Sanchez-Gistau et al., 2010), and impaired social functioning 
(Gois et al., 2011; Realmuto et al., 2015). Uncontrolled seizures in TLE also places 
individuals at an increased risk for death (Choi et al., 2008). The multifaceted 
consequences of TLE highlight the need for effective treatments for these pharmaco-
resistant seizures. 
 
 3 
Current Treatments for TLE 
Antiepileptic Drug Targets  
According to Ojemann (1997), the first line of symptom management with TLE 
patients is with antiepileptic drugs (AEDs). As such, the commonly used 
targets/mechanisms for AEDs are reviewed below. 
 
Voltage-Gated Sodium Channels 
Voltage-gated sodium channels play a significant role in the generation and 
conduction of action potentials and ultimately the cellular hyper-excitability and release 
of neurotransmitters observed in TLE (Hargus et al., 2011; Potschka, 2013). More 
specifically, when the neuronal membrane is at rest most of the voltage-gated sodium 
channels are closed. Once a change in membrane potential reaches the threshold potential 
depolarization occurs and the voltage-gated sodium channel opens allowing sodium ions 
to rapidly enter the intracellular space (Kwan, Sills, & Brodie, 2001; Potschka, 2013). 
Next, the voltage-gated channel closes and is not readily re-activated (Kwan et al., 2001). 
As the membrane is repolarized the voltage-gated sodium channel reverts back to resting 
potential allowing for future de-polarizations (Kwan et al., 2001).  
These voltage-gated sodium channels can cycle through these active and inactive 
states in milliseconds (fast-activation) or in seconds to minutes (slow-activation) as this 
plays an important role in the production of epileptic activity (Kwan et al., 2001; 
Potschka, 2013). Consequently, various AEDs have been developed to target these types 
of ion channels (Potschka, 2013). Drugs such as carbamazepine, oxacarbazepine, 
esliscabazepine acetate, phenytoin, lamotrigine, zonisamide, and felbamate promote fast 
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inactivation by blocking voltage-gated sodium channels. Conversely, lacosamide 
promotes slow inactivation (Potschka, 2013). As a result, the promotion of these effects is 
thought to protect against partial and generalized tonic-clonic seizures (Rogawski & 
Loscher, 2004). 
 
Voltage-Gated Calcium Channels 
Similarly to sodium channels, voltage-gated calcium channels are also opened by 
depolarization of the neuronal membrane and allow rapid influx of calcium ions 
(Rogawski & Loscher, 2004). These voltage-gated calcium channels can be classified as 
low voltage and high voltage (Potschka, 2013). The T-type (low voltage-gated calcium 
channels) contribute to epileptic discharges observed in sub-regions of the thalamus 
during absence seizures (Potschka, 2013). AEDs such as ethosuximide, valproate, and 
zonisamide are thought to exert their anti-epileptic properties through blocking these 
channels (Potschka, 2013).  
On the other hand, numerous high voltage-gated calcium channels (L, R, P/Q, N) 
are located on presynaptic terminals of neuronal axons and have been associated with the 
release of neurotransmitters that contribute to epileptic activity (Potschka, 2013). AEDs 
such as felbamate, gabapentin, lamotrigine, levetiracetam, phenobarbital, pregabalin, and 
topiramate are thought to exert antiepileptic effects by blocking these high voltage-gated 
calcium channels (Potschka, 2013). 
 
GABAergic Systems 
GABA is widely recognized as the most important inhibitory neurotransmitter in 
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the brain as it plays a vital role inhibiting epileptic activity in areas that vulnerable to 
epileptic discharges such as the hippocampus, amygdala, and neocortex (Potschka, 2013; 
Rogawski & Loscher, 2004). GABA exerts its inhibitory effects by binding to fast acting, 
ionotropic GABAA receptors (ligand-gated ion channels), which allows for influx of 
chloride ions resulting in neuronal hyperpolarization and reduction in excitability (Kwan 
et al., 2001; Potschka, 2013; Rogawski & Loscher, 2004). AEDs such benzodiazepines, 
felbamate, phenobarbital, retigabine, and topiramate are thought to bind to these receptors 
(Potschka, 2013).  
GABA can also exert its inhibitory effect by binding to slower acting, GABAB 
metabotropic G-protein coupled receptors, which can lead to inhibition of voltage-gated 
calcium channels and/or the increased conductance of potassium ions thereby reducing 
excitability (Kwan et al., 2001; Potschka, 2013). Other AEDs exert their inhibitory effect 
by targeting enzymes or transporters that affect the reuptake of GABA in presynaptic 
neurons or nearby glia cells (Potschka, 2013; Rogawski & Loscher, 2004). For example, 
vigabatrin inhibits GABA transaminase from degrading GABA in presynaptic neurons or 
neighboring glia cells which increases the concentration of GABA in the brain (Potschka, 
2013). Tiagabine potentiates post-synaptic GABAergic potentials by inhibiting reuptake 
in presynaptic neurons and nearby glia cells through targeting the GABA transporter, 
GAT-1 (Potschka, 2013). Lastly, AEDs like gabapentin and valproate increase GABA 
concentration in the brain by promoting GABA turnover, while levetiracetam affects of 
modulation of GABAA receptors (Potschka, 2013). 
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Glutamatergic Systems 
 In contrast to GABA, glutamate is widely recognized as the most important 
excitatory neurotransmitter in the brain (Kwan et al., 2001). Glutamate promotes fast 
excitatory neurotransmission by binding to ionotropic glutamate receptors such AMPA, 
kainate, and NMDA receptors (Potschka, 2013). Moreover, AMPA and kainate receptors 
are permeable for sodium and potassium, while NMDA receptors are permeable to 
sodium, potassium, and calcium (Potschka, 2013). Consequently, the binding of 
glutamate to these receptors results in the influx of cations into post-synaptic neurons 
which leads to neuronal excitability (Potschka, 2013). This is consistent with research 
demonstrating that focal injections of glutamate result in seizures (Kwan et al., 2001). 
Clinical efficacy for a selective glutamate receptor antagonist has not been demonstrated 
as of yet. However, AEDs with multiple mechanisms of actions such as felbamate, 
topiramate, and phenobarbital may have a glutamatergic effect (Potschka, 2013). 
 
Resective Surgery and Additional Treatments 
As TLE is the form epilepsy that is the most drug-resistant to seizures, other 
techniques such as resective surgery of the temporal lobe has been utilized to treat 
patients (Engel et al., 2012). Wiebe, Blume, Girvin, and Eliasziw (2001) in a randomized 
controlled trial demonstrated that resective surgery was superior to prolonged AED 
therapy in terms of reduced seizures and improved quality of life among TLE patients 
with poorly controlled seizures. Expanding on this study, Engel et al. (2012) also 
performed a randomized clinical trial with TLE patients that had drug-resistant seizures. 
The results showed that patients who underwent resective surgery with continued AED 
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treatment experienced significantly less seizures than individuals who only received AED 
treatment (Engel et al., 2012). In addition to surgery, other treatments options including 
vagus nerve stimulation (Aihua et al., 2014; Marras et al., 2013; Waseem, Raffa, 
Benbadis, & Vale, 2014) and the ketogenic diet (Pfeifer & Thiele, 2005; Sirven et al., 
1999) have demonstrated some benefits for the treatment of epilepsy. 
 
Rodent Models of TLE and Seizures 
             An array of animal models (e.g. cats, dogs, non-human primates, fish, worms, 
and flies) have been used to study seizures and/or epilepsy (Grone & Baraban, 2015). 
However, rodent models are the more commonly used and widely recognized paradigm 
for modeling seizures and TLE (Grone & Baraban, 2015). As a result, the major 
techniques will be examined further. 
 
Chemoconvulsant Models 
             Chemoconvulsants such as kainic acid and pilocarpine are used in rodents to 
model TLE through an initial injury such as status epilepticus, which is followed by a 
latent period before the onset spontaneous chronic seizures (Kandratavicius et al., 2014). 
The seizures are typically partial and tonic-clonic type while histopathological changes 
are reflective of TLE (Kandratavicius et al., 2014). Kainic acid is a L-glutamate analog 
and agonist for ionotropic kainate receptors in the hippocampus (Kandratavicius et al., 
2014; Levesque & Avoli, 2013). Injected rodents also typically develop degenerated 
brain tissue that models TLE hippocampal sclerosis (Kandratavicius et al., 2014).   
Injections of pilocarpine, a muscarinic acetylcholine receptor agonist, results in 
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hippocampal damage and produces lesions in the neocortex (Buckmaster, 2004; 
Kandratavicius et al., 2014). Lastly, both methods can be administered systemically or 
intrahippocampally (Kandratavicius et al., 2014; Levesque & Avoli, 2013). However, the 
drawbacks for both of these chronic epilepsy models are the experimental costs and time 
constraints (Kandratavicius et al., 2014). Other convulsant agents such as 
pentylenetetrazol (PTZ), strychnine, N-methyl-D, or L-aspartate can be used to screen 
AEDs in acute seizure models as opposed to chronic epilepsy (Kandratavicius et al., 
2014). 
 
Electrical Stimulation Models 
            In addition to chemoconvulsants, models such as electroshock-induced seizures 
and kindling have been used to study seizures (Kandratavicius et al., 2014). In the 
electroshock model, mild stimulation from corneal electrodes result in myoclonic 
seizures, while more intense stimulation can lead to generalized tonic-clonic seizures 
(Kandratavicius et al., 2014). This approach has been used to research how epileptic 
discharges can adversely impact synaptic plasticity, cognition, and co-morbid psychiatric 
conditions (Kandratavicius et al., 2014).  
The kindling method involves continuous, mild electrical stimulation of regions 
such the hippocampus, amygdala, and olfactory areas and other brain regions 
(Buckmaster, 2004). This can result in partial seizures leading to secondary 
generalization and spontaneous seizures (Kandratavicius et al., 2014). The advantages to 
these two models are the low rates of mortality and high reproducibility of findings. The 
disadvantages arise when these models are applied for chronic seizure research as the 
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process can become expensive and labor-intensive (Kandratavicius et al., 2014). 
 
Brain Pathology Models 
             Utilizing rodents also allows for modeling of febrile seizures, neonatal hypoxic 
encephalopathy, and post-traumatic epilepsy. For example, raising the body temperature 
of immature rodents results in hyperthermic seizures that model febrile seizures observed 
in childhood (Kandratavicius et al., 2014). The behavioral manifestation of these seizures 
are characterized by immobility, facial automatisms, and myoclonic jerking 
(Kandratavicius et al., 2014). The hypoxia model exposes immature rodents to air 
concentrations with low amounts of oxygen, which results in brief and repetitive tonic-
clonic seizures mimicking neonatal hypoxic encephalopathy (Kandratavicius et al., 
2014). The post-traumatic epilepsy model induces brain damage through a fluid 
percussion injury that later results in low frequency generalized tonic-clonic seizures 
(Kandratavicius et al., 2014). 
 
Genetic Models 
           Genetic models have also been used to study various types of epilepsy. More 
specifically, audiogenic seizures have been used to model not only reflex epilepsy, but 
also TLE as well (Kandratavicius et al., 2014). These seizures are induced by high-
intensity acoustic stimuli that result in wild running and tonic-clonic seizures 
(Kandratavicius et al., 2014). Various rodents strains such as Genetically Epilepsy-Prone 
Rats (GEPRs), P77PMC rats, Wistar Albino Glaxo/Rijwijk rats (WAG/Rij), Wistar 
Audiogenic Sensitive Rats, and Wistar Audiogenic Rats (WAR) have been used in 
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audiogenic seizure experiments (Kandratavicius et al., 2014). Limitations of this model 
include requiring specific auditory stimuli to evoke seizure activity and the lack of 
recurrent chronic seizures (Kandratavicius et al., 2014).  
 
Drosophila Melanogaster as a Research Model 
             Although rodent models have been effective in modeling seizures and epilepsy, 
the experiments and maintenance can be cost-prohibitive and very lengthy. On the hand, 
seizure modeling in Drosophila melanogaster is appealing due to the small size, low cost, 
and rapid transgenesis of this organism (Grone & Baraban, 2015). Additionally, 
Drosophila have 4 chromosomes and about 14,000 genes with limited redundancy in 
comparison to rodents, which makes it easier to study a particular gene’s function 
(“JoVE,” 2015). More advantages include a short life cycle (approximately 2 weeks) that 
has four major stages (embryo, larva, pupa, adult) and a 60-80 day lifespan depending on 
environmental conditions (“JoVE,” 2015). In terms of offspring, a fertile mating pair can 
produce a genetically identical progeny of hundreds within the span of 10-12 days at 25 
°C, while rodent models can only produce a limited amount of offspring every 3 to 4 
months (Pandey & Nichols, 2011). 
 With respect to the adult fruit fly brain, Drosophila have about 100,000 
neurons that have distinct connections that mediate a variety of behaviors such as 
learning and memory, courtship, aggression, feeding, grooming, circadian rhythms, sleep, 
and flight navigation (Pandey & Nichols, 2011). Notably, voltage-gated and ligand-gated 
channels have highly conserved homologues in Drosophila (Parker, Howlett, Rusan, & 
Tanouye, 2011). GABA, glutamate, and acetylcholine neurotransmitter receptors also 
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have highly conserved homologues (Parker, Howlett, et al., 2011). Moreover, about 50% 
this species’ genes originate from a common ancestor as humans and 75% of human-
disease related genes are orthologous or function similarly in Drosophila (“JoVE,” 2015). 
As such, these advantages make Drosophila a viable alternative to rodents for studying 
pharmaco-resistant epilepsy and testing anticonvulsants. 
 
Seizure Modeling in Drosophila Melanogaster 
           The Bang-Sensitive class of Drosophila mutants experience seizure-like activity 
(SLA) following mechanical stimuli that can be used to model intractable epilepsy in 
humans. Following mechanical shock either by tapping or vortexing a vial, Bang-
Sensitive mutants undergo an initial seizure (2 seconds), temporary paralysis (20-300 
seconds), and then a recovery seizure (2 seconds) (Song & Tanouye, 2008) (see Figure 
1). Lastly, there is a refractory period where seizures cannot be induced and then a 
complete recovery period where the mutants regain seizure-sensitivity (Parker, Howlett, 
et al., 2011) (see Figure 1). SLA in Bang-Sensitive mutants can also be induced through 
high frequency electrical stimulation, as they have much lower electrophysiological 
seizure thresholds (usually 10 V) than their wild-type counterparts (usually 30 V) (Song 
& Tanouye, 2008). 
 
 
 12 
 
Figure 1. Following mechanical shock Bang-Sensitive mutants undergo an initial seizure, 
temporary paralysis, and then a recovery seizure before returning to baseline. Image from 
“Regulation of membrane excitability: A convergence on voltage-gated sodium 
conductance,” by W. Lin and R. A. Baines, 2015, Molecular Neurobiology, 51, p. 60. © 
The Author(s) 2014  
 
 
The are six canonical mutant strains which include bang senseless (bss), bang 
sensitive (bas), easily shocked (eas), slamdance (sda), technical knockout (tko), and 
knockdown (kdn) (Song & Tanouye, 2008). The bss1 and eas2 strains are completely 
penetrant with respect to expressing seizure-like activity (Song & Tanouye, 2008) and 
were utilized in this study. The bss1 strain has a mutation that affects voltage-gated 
sodium channels by shifting the voltage of fast inactivation to more positive potentials 
without any effect on activation voltage (Parker, Padilla, Du, Dong, & Tanouye, 2011). 
This results in tonic-clonic seizure-like activity following mechanical shock, as this 
mutant is the most severe of the Bang-Sensitive mutants (Song & Tanouye, 2008). 
Moreover, the bss strain is viewed as a model of intractable epilepsy due to the difficulty 
to pharmacologically and genetically suppress the strain’s severe seizure-sensitivity 
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(Parker, Padilla, et al., 2011; Song & Tanouye, 2008).  
Mutants from the eas2 strain have an ethanolamine kinase defect that impairs the 
synthesis of phosphatidylethanolamine, which is a primary membrane lipid in Drosophila 
(Pavlidis, Ramaswami, & Tanouye, 1994; Song & Tanouye, 2008). As a result, this 
defect is thought to increase hyper-excitability by affecting integral membrane proteins 
such as ion channels or through membrane fusion events like neurotransmitter secretion 
as these mutants display moderate seizure sensitivity (Pavlidis et al., 1994; Song & 
Tanouye, 2008). 
 
Anticonvulsant Studies with bss and eas Mutants 
             As SLA in Bang-Sensitive mutants models drug-resistant epilepsy in humans, 
multiple experiments with bss and eas mutants have been performed to screen AED 
treatments (Baraban, 2007). Kuebler and Tanouye (2002) demonstrated that head 
injections of valproate reduced seizure-sensitivity in bss mutants during high frequency 
electrical stimulation. Next, Reynolds et al. (2004) examined seizure modeling after 
treating eas and bss strains with a range of AEDs. For eas mutants, Reynolds et al. (2004) 
observed that acute feeding with AEDs such as carbamazepine, ethosuximide, and 
vigabatrin had no significant effect on seizure recovery time following mechanical shock. 
However, acute feeding with phenytoin at a range doses significantly reduced seizure 
recovery time for eas mutants (Reynolds et al., 2004). For chronic feeding, phenytoin and 
gabapentin at a range of doses significantly reduced seizure recovery time following 
mechanical shock, while ethosuximide only had a significant effect at a higher dosage 
(Reynolds et al., 2004). Additionally, chronic exposure to phenytoin reduced seizure 
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sensitivity to high frequency electrical stimulation (Reynolds et al., 2004). For bss 
mutants, feeding gabapentin reduced seizure recovery time in a strain-specific manner, 
while phenytoin’s anticonvulsant effect was dose-dependent (Reynolds et al., 2004). 
           In another study, Tan, Lin, and Tanouye (2004) examined the anticonvulsant 
effects of potassium bromide on bss and eas strains. The results demonstrated that there 
was significant improvement for seizure recovery time in response to mechanical and 
electrical stimulation for bss mutants as these effects were dependent on the 
concentration and feeding duration of potassium bromide; however, this AED was 
ineffective for eas mutants (Tan et al., 2004).  
Stone, Evans, Coleman, and Kuebler (2013) employed genetic and non-traditional 
pharmacological manipulations to up-regulate metabolism in bss and eas mutants to 
reduce SLA. More specifically, they introduced the atusugari (atu) mutation to increase 
the metabolic rate (Stone et al., 2013). After receiving mechanical shock, both strains 
with the atu mutation exhibited reduced SLA (Stone et al., 2013). Eas mutants with the 
atu mutation also displayed increased levels of metabolism in comparison to their single 
mutant counterparts (Stone et al., 2013). 
 With respect to the drug treatment, both strains were fed tolbutamide, which is 
associated with increased hemolymph and lipid metabolism (Stone et al., 2013). The 
results demonstrated that eas flies exhibited reduced SLA and faster recovery following a 
mechanical shock in comparison to their counterparts that did not receive the drug (Stone 
et al., 2013). On the other hand, the bss flies did not experience a significant reduction in 
SLA, but did exhibit faster recovery times in comparison to bss flies that did not receive 
tolbutamide (Stone et al., 2013). Lastly, Stone, Burke, Pathakamuri, Coleman, and 
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Kuebler (2014) demonstrated that the eas mutants who were fed metformin (used to treat 
type II diabetes) exhibited reduced SLA. 
 In summary, these studies demonstrate that the standard AEDs and non-
traditional treatments used to treat intractable epilepsy in humans have varying levels of 
efficacy in Bang-Sensitive mutants. Consequently, developing new and innovative types 
of anticonvulsive treatments in Bang-Sensitive mutants will have important research 
implications for drug-resistant seizures observed in TLE patients. More specifically, new 
treatments could possibly mitigate the neurological, cognitive, and psychological 
outcomes in TLE and reduce increased risk for death associated with uncontrolled 
seizures. Additionally, individuals treated with the commonly used AEDs can have 
neurocognitive side effects (Arif et al., 2009; Javed et al., 2015; Kwan & Brodie, 2001; 
Ortinski & Meador, 2004) as well as psychiatric and behavioral problems (Weintraub, 
Buchsbaum, Resor, & Hirsch, 2007), which further highlights the need for additional 
treatments. As a result, a novel and alternative anticonvulsive treatment for the two Bang-
Sensitive mutants in this prospective study will be discussed next. 
 
Properties of Ellagic Acid 
            Ellagic acid (EA), a naturally occurring polyphenol, is present in a variety of 
fruits and nuts including pomegranates (Panichayupakaranant, Itsuriya, & Sirikatitham, 
2010), Indian gooseberries (Poltanov et al., 2009), raspberries (Bobinaitė, Viškelis, & 
Venskutonis, 2012), strawberries (Kosmala et al., 2014), walnuts (Anderson et al., 2001), 
pecans (Malik et al., 2009), and chestnuts (Gonçalves et al., 2010). Furthermore, EA 
appears to have neuro-protective (Dolatshahi, Farbood, Sarkaki, Mansouri, & Khodadadi, 
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2015; Farbood et al., 2015), anti-inflammatory (Farbood et al., 2015; Papoutsi et al., 
2008), antioxidant (Al-Obaidi et al., 2014; Yu, Chang, Wu, & Chiang, 2005), anxiolytic 
(Girish, Raj, Arya, & Balakrishnan, 2013), and anti-depressant (Dhingra & Chhillar, 
2012; Ferreres, Grosso, Gil-Izquierdo, Valentão, & Andrade, 2013) properties. 
 
Potential Mechanism of Action for Ellagic Acid 
Research has demonstrated that EA has anticonvulsant properties as well. 
Dhingra and Jangra (2014) examined the acute and chronic effects of EA in mice 
following pentylenetetrazol (PTZ) and picrotoxin-induced (PTX) convulsions. PTZ 
triggers convulsions by exerting an inhibitory effect on GABA-mediated chloride ion 
influx via an allosteric interaction at chloride ion channels, which leads to the activation 
of excitatory neurons, excitotoxicity and ultimately seizures (Dhingra & Jangra, 2014). 
PTX is a non-competitive GABAA receptor antagonist that blocks chloride ion channels 
which leads to convulsions as well (Dhingra & Jangra, 2014).  
The study demonstrated that acute and chronic administration of EA delayed 
the onset of convulsions, while also reducing the duration of tonic and clonic convulsions 
and mortality in both PTZ and PTX conditions (Dhingra & Jangra, 2014). EA 
significantly increased levels of GABA in the brain as well (Dhingra & Jangra, 2014). As 
a result, Dhingra and Jangra (2014) asserted that EA’s anticonvulsant effects most likely 
involve GABAergic neurotransmission. Additionally, Girish et al. (2013) demonstrated 
that EA had an anxiolytic effect on mice that was antagonized by PTX and flumazenil 
(FL) (a benzodiazepine site antagonist). This further provided evidence that EA possibly 
exert its effects through the GABAergic system. 
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 Further investigating this potential GABAergic mechanism for EA is critical 
since decreased levels of GABA in the brain have been linked to poorer seizure control 
(Petroff, Rothman, Behar, & Mattson, 1996) as hyper-excitability is a defining feature of 
epilepsy (Fisher et al., 2005). Moreover, utilizing Bang-Sensitive Drosophila provide an 
excellent opportunity to study this mechanism of action since they have highly conserved 
homologues with humans with respect to GABAergic neurons (Liu, Krause, & Davis, 
2007; Parker, Howlett, et al., 2011).   
The purpose study of this study was to evaluate the usefulness of seizure 
modeling in the bss and eas strains and examine the potential anticonvulsant properties of 
EA while attempting to block this effect with GABA antagonists (FL and PTX) to better 
understand its role in GABAergic neurotransmission. This will expand on the prior 
research performed with Bang-Sensitive mutants as none of the previously cited studies 
utilized polyphenols or attempted to block the effect of anticonvulsants to clarify the 
mechanism of action.  
 
Aims of Study 
 Aim 1: Determine the effects of seizure modeling with mechanical shock in Bang-
Sensitive mutants. 
Hypothesis: Vortexing individual bss and eas mutants will induce SLA. Rationale: Bang-
Sensitive mutants display SLA following mechanical shock, which will be assessed in 
terms of duration, distance moved, and velocity. 
 Aim 2: Determine the anticonvulsive effects of EA on SLA. 
Hypothesis: Dietary supplementation with EA will reduce the SLA of Bang-Sensitive 
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mutants. Rationale: The anticonvulsant properties of EA will reduce SLA with respect to 
duration, distance moved, and velocity. Two-day old, adult male bss and eas flies will be 
fed either standard media or standard media mixed with EA. 
 Aim 3: Determine if the anticonvulsive effects of EA on SLA can be 
pharmacologically blocked. 
Hypothesis: The anticonvulsant effects of EA on Bang-Sensitive mutants will be blocked 
by GABA antagonists. Rationale: EA is thought to exert its anticonvulsive properties 
through GABAergic transmission. As a result, this effect should be blocked by either FL 
(a benzodiapine site antagonist) or PTX (non-competitive GABAA receptor antagonist). 
This should result in increased SLA with respect to duration, distance moved, and 
velocity. Two-day old, adult male bss and eas flies will be fed standard media mixed with 
EA + FL or standard media mixed EA + PTX. 
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CHAPTER TWO 
RESARCH DESIGN 
 
 
Methods 
Fly Stocks 
             The bss1 and eas2 strains were obtained from Dr. Daniel Kuebler at the 
Franciscan University of Steubenville. The stocks were maintained and housed in two 
population boxes (see Figure 2A). They were cultured on Formula 4-24® Instant 
Drosophila Medium, Blue (Carolina Biological Supply, Burlington, NC) at an average 
temperature of 75 °F on a 12hr/12hr light-dark cycle (see Figure 2A). Eggs for the 
experiment were then collected from food plates as needed and placed into vials with 1 
teaspoon of media (see Figure 2B). After approximately two weeks, newly eclosed flies 
were collected and used for the study. 
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A.	 	 	 	 	 	 B.	
	  
 
Figure 2. Equipment used for Drosophila husbandry. (A) Population boxes along with 
supplementary vials that were used to maintain the respective mutant stocks. (B) Vials 
that were used to develop experimental bss and eas flies for the study. 
 
 
 
Selection of Treatment Doses 
 Pomegranate extract powder (90% ellagic acid) (PureBulk, Roseburg, OR), PTX 
(INDOFINE Chemical Company, Hillsborough, NJ), and FL (Enzo Life Sciences, 
Farmingdale, NY) were used for the experiment. The PTX solution was made 
by dissolving 100 mg of PTX in 1 mL of DMSO and then diluting with 200 mL water. 
The FL solution was made by dissolving 5 mg of FL in 1 mL of DMSO and then diluting 
with 1L water. The EA dose was based on prior polyphenol research with Drosophila 
(Wang et al., 2015). Likewise, the PTX dose was based on prior PTX research with 
Drosophila (Stilwell, Saraswati, Littleton, & Chouinard, 2006). The FL dose was derived 
from research with Daphnia pulex (Dong, Hu, Ni, Zuo, & Li, 2013) as there were no 
studies to date using FL for seizure modeling in Drosophila. 
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Experimental Groups 
  Newly emerged adult males were given the standard media diet for 48 hours. 
Next, they were anesthetized with FlyNap and individually placed in vials where they 
were randomly assigned to receive 48 hours of one of four treatments: control diet (½ 
teaspoon of standard media), EA treatment (25 mg of pomegranate extract powder mixed 
with standard media), EA + FL treatment (2.5 mL of FL solution added to EA and 
standard media) or EA + PTX treatment (2.5 mL of PTX solution added to EA and 
standard media). Twenty-eight males were assigned to each diet condition across both 
strains for a total of 224 flies in the study (see Table 1). 
 
 
Table 1. Experimental group breakdown. 
 Standard 
Media 
EA EA + FL EA + PTX 
            bss 28 28 28 28 
            eas 28 28 28 28 
 
 
 
Seizure-like Activity Assay 
 This assay was based on the method performed by Stone et al. (2014). After the 
two-day drug-feeding period, flies were transferred to individual vials where they were 
undisturbed for least 20-30 minutes. None of the flies were exposed to anesthesia over 
the prior 48-hour period. Next, individual vials were vortexed on the maximum setting 
(Scilogex MX-S Vortex Mixer) for 10 seconds (see Figure 3A). Then single flies were 
placed on a white sheet of paper underneath a webcam (Logitech C270) and covered with 
a Petri dish with air slits (see Figure 3B). Seizure activity was recorded with HandyAvi 
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time-lapse picture software. The image stacks were processed using ImageJ multitracker 
software and yielded raw pixel x-y coordinates for each fly. This data was then converted 
to seizure information such as duration (s), distance moved (cm), and velocity (cm/s) 
with a custom Excel Visual Basic Program (Fly Analysis Software) created by Stone et 
al. (2014). 
 
 
A.	 	 	 	 	 	 B.	
	 	
 
Figure 3. Equipment used for seizure assay. (A) Vortexer on highest setting. (B) 
Recording setup including webcam, white sheet of paper, and Petri dish. 
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Figure 4. Schematic diagram of experiment. 
 
 
Collect	Newly	Emerged	
Flies	At	Approximately	2	
Weeks	
Feed	Standard	Media	For	
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Anesthetize	With	FlyNap		
Randomly	Assign	To	
Individual	Treatment	Vials	
For	48	Hours	
Perform	Seizure	Assay	
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Statistical Analysis 
 SPSS was used to perform all of the statistical tests. Prism was used to generate 
graphs. Three 2-way ANOVAs with Bonferroni post hoc tests were performed with 
genotype and diet on the dependent variables of duration, distance moved, and velocity. 
This approach was used instead of a MANOVA due to the linear dependency of velocity 
with duration of SLA and distance moved during SLA. This method was also utilized 
over a MANOVA due to the significant, positive correlations between duration of SLA 
and distance moved during SLA observed in both genotypes and all diet conditions (see 
Results). Flies that did not exhibit SLA were removed from the analysis (n = 14), which 
resulted in 25-28 flies per diet condition (see Table 2). Chi-Square analyses demonstrated 
that non-seizing flies that were removed did not differ significantly from the remaining 
flies with respect to genotype or diet (p > .05). The Kolmogorov-Smirnov Test 
demonstrated that the data met assumptions for normality. 
 
 
Table 2. Experimental group breakdown with non-seizing flies removed. 
 Standard Media EA EA + FL EA + PTX 
            bss 27 (96.4%) 25 (89.3%) 26 (92.9%) 27 (96.4%) 
            eas 26 (92.9%) 26 (92.9%) 25 (89.3%) 28 (100%) 
Percentage of remaining flies in each condition in parentheses 
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CHAPTER THREE 
RESULTS 
 
 
Main Effect of Genotype 
There was no significant main effect for genotype on duration of SLA as bss 
flies (M = 6.16 s) did not differ significantly from eas flies (M = 5.84 s), F(1, 202) = .68, 
p > .05 (see Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5. There was no significant difference in duration of SLA between bss and eas 
flies. The data point color corresponds to diet condition (blue = control; red = ellagic 
acid; green = ellagic acid + flumazenil; purple = ellagic acid + picrotoxin). 
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 There was no significant main effect for genotype on distance moved during SLA 
as bss flies (M = 14.23 cm) did not differ significantly from eas flies (M = 12.16 cm), 
F(1, 202) = 2.46, p = .12 (see Figure 6). 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. There was no significant difference in distance moved during SLA between bss 
and eas flies. The data point color corresponds to diet condition (blue = control; red = 
ellagic acid; green = ellagic acid + flumazenil; purple = ellagic acid + picrotoxin). 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among bss flies, r = .76, p < .001 (see Figure 7). 
 
 
 
Figure 7. In bss flies, there was a significant, direct relationship between distance moved 
during SLA and duration of SLA, r = .76, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among eas flies, r = .83, p < .001 (see Figure 8). 
 
 
 
Figure 8. In eas flies, there was a significant, direct relationship between distance moved 
during SLA and duration of SLA, r = .83, p < .001. 
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 There was a significant main effect for genotype on velocity of SLA. Bss flies (M 
= 2.27 cm/s) had significantly higher velocity of SLA than eas flies (M = 1.98 cm/s), F(1, 
202) = 5.04, p < .05 (see Figure 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Bss flies had significantly higher velocity of SLA than eas flies. The data point 
color corresponds to diet condition (blue = control; red = ellagic acid; green = ellagic acid 
+ flumazenil; purple = ellagic acid + picrotoxin). *p < .05 
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Main Effect of Diet 
There was a significant main effect for diet, F(1, 202) = 15.61, p < .001. The 
Bonferroni post hoc test revealed that duration of SLA was significantly higher for the 
EA + PTX condition (M = 8.25 s) when compared to the control (M = 4.87 s) (p < .001), 
EA (M = 4.29 s) (p < .001), and EA + FL conditions (M = 6.45 s) (p < .05) (see Figure 
10). Duration of SLA was higher for the EA + FL condition (M = 6.45 s) when compared 
to the EA (M = 4.29 s) (p < .05) and control (M = 4.87 s) (p < .01) condition (see Figure 
10). Flies in the EA condition (M = 4.29 s) did not significantly differ from controls (M = 
4.87 s) (p > .05) (see Figure 10). 
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Figure 10. EA + PTX flies had significantly longer duration of SLA when compared to 
all other conditions. EA + FL flies had significantly longer duration of SLA when 
compared to the EA and control conditions. Flies on the EA diet did not differ 
significantly from controls. *p < .05; **p < .01; ***p < .001 
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  There was no significant main effect for diet. Distance moved during SLA did not 
differ significantly among the control (M = 13.14 cm), EA (M = 11.22 cm), EA + FL (M 
= 12.62 cm), and EA + PTX conditions (M = 15.61 cm), F(1, 202) = 2.46, p = .12 (see 
Figure 11). 
 
 
 
  
 
  
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. There was no significant difference in distance moved during SLA among diet 
conditions. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among flies receiving the control diet, r = .82, p < .001 (see 
Figure 12). 
 
 
Figure 12. In control flies, there was a significant, direct relationship between distance 
moved during SLA and duration of SLA, r = .82, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among flies receiving EA, r = .77, p < .001 (see Figure 13). 
 
 
 
Figure 13. In EA flies, there was a significant, direct relationship between distance 
moved during SLA and duration of SLA, r = .77, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among flies receiving EA + FL, r = .84, p < .001 (see Figure 
14). 
 
Figure 14. In EA + FL flies, there was a significant, direct relationship between distance 
moved during SLA and duration of SLA, r = .84, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among flies receiving EA + PTX, r = .86, p < .001 (see Figure 
15). 
 
Figure 15. In EA + PTX flies, there was a significant, direct relationship between 
distance moved during SLA and duration of SLA, r = .86, p < .001. 
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 There was a significant main effect for diet, F(1, 202) = 6.51, p < .001. The 
Bonferroni post hoc test revealed that velocity of SLA was significantly lower for the EA 
+ PTX condition (M = 1.83 cm/s) when compared to the control (M = 2.46 cm/s) (p < 
.05) and EA (M = 2.39 cm/s) (p < .05) conditions (see Figure 16). Velocity of SLA was 
significantly lower for the EA + FL condition (M = 1.82 cm/s) when compared to the 
control (M = 2.46 cm/s) (p < .05) and EA (M = 2.39 cm/s) (p < .05) conditions (see 
Figure 16). The EA condition (M = 2.39 cm/s) did not significantly differ from the 
control condition (M = 2.46 cm/s) (p > .05) (see Figure 16). 
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Figure 16. EA + PTX flies had significantly lower velocity of SLA when compared to 
the EA and control conditions. EA + FL flies had significantly lower velocity of SLA 
when compared to the EA and control conditions. *p < .05 
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Interaction Effect of Genotype and Diet 
 There was a significant interaction effect between genotype and diet on duration 
of SLA, F(3, 202) = 4.44, p < .05. The Bonferroni post hoc test revealed that duration of 
SLA in the EA condition was lower for eas flies  (M = 3.19 s) when compared to bss flies 
(M = 5.43 s) (p < .05) (see Figure 17). Duration of SLA in the EA + PTX condition was 
higher for eas flies (M = 9.18 s) when compared to bss flies (M = 7.30 s) (p < .05) (see 
Figure 17).  
There were no significant differences in duration of SLA among the control (M 
= 5.65 s), EA (M = 5.43 s), EA + FL (M = 6.22 s), and EA + PTX (M = 7.30 s) conditions 
for bss flies (p > .05) (see Figure 17). In eas flies, duration of SLA was higher for the EA 
+ FL condition (M = 6.69 s) when compared to the control (M = 4.07 s) (p < .05) and EA 
(M = 3.19 s) (p < .01) conditions (see Figure 17). Duration of SLA was higher for the EA 
+ PTX condition (M = 9.18 s) when compared to the control (M = 4.07 s) (p < .001), EA 
(M = 3.19 s) (p < .001), and EA + FL (M = 6.69 s) (p < .05) conditions for eas flies (see 
Figure 17). The EA condition (M = 3.19 s) did not differ significantly from the control 
condition (M = 4.07 s) in eas flies (p > .05) (see Figure 17). 
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Figure 17. In the EA condition, eas flies exhibited significantly less duration of SLA 
when compared to bss flies. In the EA + PTX condition, eas flies’ duration of SLA was 
significantly higher when compared to bss flies. Among bss flies, there were no 
significant differences in duration of SLA. In eas flies, duration of SLA was significantly 
higher for the EA + FL and EA + PTX diets when compared to the EA and control 
conditions. Duration of SLA was also higher for the EA + PTX diet when compared to 
the EA + FL condition. There was no significant difference between the EA and control 
conditions. *p < .05; **p < .01; ***p < .001 
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 There was a significant interaction effect between genotype and diet on distance 
moved during SLA, F(3, 202) = 3.74, p < .05. The Bonferroni post hoc test revealed that 
distance moved during SLA in the control condition was greater for bss flies (M = 16.87 
cm) when compared to eas flies (M = 9.27) (p < .05) (see Figure 18).  
There were no significant differences in distance moved during SLA among the 
control (M = 16.87 cm), EA (M = 13.62 cm), EA + FL (M = 13.07 cm), and EA + PTX 
(M = 13.28 cm) conditions for bss flies (p > .05) (see Figure 18). In eas flies, distance 
moved during SLA was greater for the EA + PTX condition (M = 17.86 cm) when 
compared to the control (M = 9.27 cm) (p < .05) and EA (M = 8.91 cm) (p < .05) 
conditions (see Figure 18). The EA condition (M = 8.91 cm) did not significantly differ 
from the control condition (M = 9.27 cm) in eas flies (p > .05) (see Figure 18). 
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Figure 18. In the control condition, bss flies exhibited greater distance moved during 
SLA when compared eas flies. Among bss flies, there were no significant differences in 
distance moved during SLA. In eas flies, distance moved during SLA was significantly 
higher for the EA + PTX diet when compared to the EA and control diets. There was no 
significant difference between the EA and control conditions. *p < .05 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among bss control flies, r = .90, p < .001 (see Figure 19). 
 
 
 
Figure 19. In bss control flies, there was a significant, direct relationship between 
distance moved during SLA and duration of SLA, r = .90, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among eas control flies, r = .73, p < .001 (see Figure 20). 
 
 
 
Figure 20. In eas control flies, there was a significant, direct relationship between 
distance moved during SLA and duration of SLA, r = .73, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among bss EA flies, r = .68, p < .001 (see Figure 21). 
 
 
 
Figure 21. In bss EA flies, there was a significant, direct relationship between distance 
moved during SLA and duration of SLA, r = .68, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among eas EA flies, r = .86, p < .001 (see Figure 22). 
 
 
 
Figure 22. In eas EA flies, there was a significant, direct relationship between distance 
moved during SLA and duration of SLA, r = .86, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among bss EA + FL flies, r = .81, p < .001 (see Figure 23). 
 
 
 
Figure 23. In bss EA + FL flies, there was a significant, direct relationship between 
distance moved during SLA and duration of SLA, r = .81, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among eas EA + FL flies, r = .93, p < .001 (see Figure 24). 
 
 
 
Figure 24. In eas EA + FL flies, there was a significant, direct relationship between 
distance moved during SLA and duration of SLA, r = .93, p < .001. 
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There was a significant, positive correlation between distance moved during 
SLA and duration of SLA among bss EA + PTX flies, r = .88, p < .001 (see Figure 25). 
 
 
 
Figure 25. In bss EA + PTX flies, there was a significant, direct relationship between 
distance moved during SLA and duration of SLA, r = .88, p < .001. 
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There was a significant, positive correlation between distance moved during SLA 
and duration of SLA among eas EA + PTX flies, r = .82, p < .001 (see Figure 26). 
 
 
 
Figure 26. In eas EA + PTX flies, there was a significant, direct relationship between 
distance moved during SLA and duration of SLA, r = .82, p < .001. 
 
 
 
 
 
 
 
 
 
0 5 10 15 20
0
10
20
30
40
Duration of SLA (s)
D
is
ta
nc
e 
M
ov
ed
 d
ur
in
g 
SL
A 
(c
m
)
r = .82
 51 
 There was a significant interaction effect between genotype and diet, F(3, 202) = 
4.44, p < .05. The Bonferroni post hoc test revealed that velocity of SLA in the control 
condition was higher for bss flies (M = 2.84 cm/s) when compared to eas flies (M = 2.06 
cm/s) (p < .01) (see Figure 27). 
Velocity of SLA in the EA + FL condition (M = 2.08 cm/s) was significantly 
lower when compared to the control condition (M = 2.84 cm/s) (p < .05) for bss flies (see 
Figure 27). Velocity of SLA for the EA + PTX condition (M = 1.76 cm/s) was 
significantly lower when compared to the control condition (M = 2.84 cm/s) (p < .001) 
for bss flies (see Figure 27). The EA condition (M = 2.41 cm/s) did not significantly 
differ from the control condition (M = 2.84 cm/s) in bss flies (p > .05) (see Figure 27). In 
eas flies, the EA + FL condition (M = 1.56 cm/sec) velocity of SLA was significantly 
lower when compared to the EA condition (M = 2.06 cm/sec) (p < .05) (see Figure 27). 
The EA condition did not significantly differ from the control condition in eas flies (p > 
.05) (see Figure 27). 
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Figure 27. In the control condition, bss flies had significantly higher velocity of SLA 
when compared eas flies. Among bss flies, velocity of SLA was significantly lower for 
the EA + FL and EA + PTX diets when compared to the control condition. There was no 
significant difference between the EA and control conditions. In eas flies, velocity of 
SLA was significantly lower for the EA + FL diet when compared to the EA condition. 
There was no significant difference between the EA and control conditions. *p < .05; **p 
< .01; ***p < .001 
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Figure 28. Representative path lengths of individual eas flies during SLA. (A) Path 
of an eas control mutant. (B) Path of an eas EA mutant. (C) Path of an eas EA + FL 
mutant. (D) Path of an eas EA + PTX mutant. 
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Figure 29. Representative path lengths of individual bss flies during SLA. (A) Path 
of a bss control mutant. (B) Path of a bss EA mutant. (C) Path of a bss EA + FL 
mutant. (D) Path of a bss EA + PTX mutant. 
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CHAPTER FOUR 
DISCUSSION 
 
The first aim of the study was to examine the effects of seizure modeling with 
mechanical shock in bss and eas flies. Vortexing for 10 seconds reliably induced seizures 
in 93.8% of both strains. Duration and distance moved were positively associated and 
effectively assessed SLA; however, using velocity as a dependent variable was a 
limitation of this model. Velocity was susceptible to being depressed as duration of SLA 
severity increased. As a result, this variable did not always truly reflect heightened SLA 
intensity due to its dependency on duration and distance moved expressed as a ratio 
(cm/s). 
Although main effects demonstrated that bss and eas strains had similar SLA 
overall, examining both control groups showed that bss flies exhibited almost twice as 
much SLA as eas flies with respect to distance moved (~16 cm vs ~9 cm). This provides 
additional support for research indicating that bss flies exhibit severe tonic-clonic SLA 
(Parker, Padilla, et al., 2011). These heterogeneous behavioral phenotypes (see Figures 
28A and 29A) may be reflective of the differences in mutations affecting voltage-gated 
sodium channels in bss flies and phospholipid membrane composition in eas flies. 
The next aim was to explore the anticonvulsant effects of EA on SLA in both 
strains of mutants. In bss and eas flies, EA reduced SLA when compared to controls; 
however these effects were non-significant. When comparing both strains, eas flies 
exhibited significantly less duration of SLA than bss flies (~3 s vs ~5 s). This is 
consistent with prior research, which demonstrated that bss flies are generally more 
resistant to the effects of anticonvulsant drugs than eas flies (Parker, Padilla, et al., 2011; 
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Song & Tanouye, 2008). These findings support that SLA in bss flies models drug-
resistant seizures observed in intractable epilepsy with tonic-clonic seizures and severe 
myoclonic epilepsy which in both instances result from the mutation of the human NaV 
SCN1A (Parker, Padilla, et al., 2011). In addition, this novel application of EA 
demonstrates that utilizing Bang-Sensitive mutants with varying levels of seizure-
sensitivity provide an effective drug-screening tool for refractory epilepsy in humans. 
Moreover, compounds found in plants may provide prophylactic benefits with regard to 
seizure severity. 
The final aim was to determine the potential mechanism of action for EA by 
blocking its anticonvulsant effects through GABA antagonists. In bss flies, the EA + FL 
and EA + PTX diets slightly increased duration of SLA when compared to control and 
EA conditions; however, this effect was non-significant. Among eas flies, both GABA 
antagonists significantly increased SLA when compared to control and EA diets, as PTX 
exhibited the strongest convulsant effect.  
In examining genotype differences, PTX was also more effective for eas flies 
than bss flies with respect to inducing SLA following mechanical shock. PTX’s strong 
convulsant effect in this study aligned with prior research demonstrating that this GABA 
antagonist significantly increased SLA in wild-type Drosophila larvae (Canton-S strain) 
through a GABAA receptor pathway (Stilwell et al., 2006). With respect to FL, this 
research provides evidence that this GABA antagonist may be useful as a pro-convulsant 
in Drosophila seizure modeling, as no studies to date have employed this approach. 
Overall, these findings with two types of GABA antagonists suggest that EA’s 
anticonvulsant effect involves GABAergic systems in a strain-specific manner and may 
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be more likely mediated through a GABAA receptor site than benzodiazepine site. 
 
Future Directions 
For prospective studies, additional PTX and FL only conditions need to be 
administered at a range of doses and compared to control diets to further clarify the 
convulsant properties of these two GABA antagonists in both bss and eas mutants. Non-
seizure-sensitive flies (i.e., Canton-S strain) should also be vortexed to confirm that they 
do not exhibit SLA after mechanical shock. Next, these flies should be administered pro-
convulsants like PTX and FL to determine if this makes them vulnerable to seizures after 
vortexing. Then, EA could be administered to determine if this potential seizure 
susceptibility can be ameliorated. 
Future research should also include examining the effect of EA at a higher range 
of doses to determine if this leads to greater reductions in SLA, especially for bss flies 
that exhibited a non-significant decrease in seizure behavior. Additionally, EA should be 
administered in combination with other pomegranate polyphenols to explore any 
synergistic effects, as Seeram et al. (2005) demonstrated that pomegranate juice can have 
greater bioactivity when compared to its purified polyphenols. Moreover, this analysis is 
warranted as research from the LLU Behavioral Neuroscience Lab has demonstrated the 
beneficial effects of pomegranate juice for memory in humans following heart surgery 
(Ropacki, Patel, & Hartman, 2013) and for Alzheimer’s disease pathology (Hartman et 
al., 2006) and radiation (Dulcich & Hartman, 2013) in rodent models. 
Lastly, because pharmaco-resistant seizures in TLE are associated with cognitive 
deficits as well as with hippocampal sclerosis and damage to other regions of the brain, 
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EA’s neuro-protective properties (Dolatshahi et al., 2015; Farbood et al., 2015) should be 
explored with this model. Histological analyses along with learning and memory assays 
could prove beneficial for investigating the relationships among SLA, brain cells, and 
cognitive functioning following the administration of EA, FL, and PTX.  
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